a
new study
adds urgency to treating cancer as soon as possible, with researchers finding that even a four-week delay can lead to an increase in mortality by about 10 per cent in many cases. the risk rises the longer the wait.
a team of researchers from canada and the u.k. reviewed cancer studies published between january 2000 and april 2020. altogether, the 34 studies looked at seven different cancers — bladder, breast, colon, rectum, lung, cervix, and head and neck — and 1.2 million patients globally. the studies contained data on surgical interventions, systemic therapy such as chemotherapy and radiotherapy.
the team’s analysis,
published
in the bmj, emphasizes the risks associated with delaying treatment: patients had a six to 13 per cent higher risk of dying when treatment was delayed by four weeks. in the example of breast cancer surgery specifically, a four-week delay was associated with an excess risk of 10 deaths among 1,000 patients; a 12-week delay was associated with 31 deaths.
“in light of these results, policies focused on minimizing system level delays in cancer treatment initiation could improve population level survival outcomes,” says dr. timothy hanna, a member of the research team and investigator with the ontario cancer research institute at queen’s university.